Skip to main navigation Skip to search Skip to main content

Can administrative data be used to measure chemotherapy side effects?

Alison Pearce, Marion Haas, Rosalie Viney, Philip Haywood, Sallie-Anne Pearson, Kees Van Gool, Preeyaporn Srasuebkul, Robyn Ward

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Many of the issues with using data from clinical trials and observational studies for economic evaluations are highlighted in the case of chemotherapy side effects. We present the results of an observational cohort study using linked administrative data. The chemotherapy side effects identified in the administrative data are compared with patient self-reports of such events. The results of these comparisons are then used to guide a discussion of the issues surrounding the use of administrative data to identify clinical events for the population of economic models. Although the advantages of easy access and generalizability of the results make administrative data an attractive option for populating economic models, this is not always possible because of the limitations of these data.

Original languageEnglish
Pages (from-to)215-222
Number of pages8
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume15
Issue number2
DOIs
Publication statusPublished - Apr 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cancer
  • chemotherapy
  • clinical trials
  • economic evaluation
  • observational data

Cite this